Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Filings indexed 931 across all filing types
Latest filing 2011-03-18 Annual Report
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
第七届董事会第四次会议决议公告
Annual Report Classification · 95% confidence The document is a detailed announcement of resolutions passed at the company's seventh board meeting, including approval of the 2010 annual board work report, independent directors' report, general manager's report, and the 2010 financial final accounts report audited by an accounting firm. It also includes approval of the 2010 profit distribution plan, appointment of the 2011 audit firm, and other corporate governance matters. The document contains substantive financial data for the 2010 fiscal year, including revenue, net profit, earnings per share, equity, assets, and cash flow figures. The presence of comprehensive financial results and management reports for the full fiscal year indicates this is an Annual Report type document rather than a brief announcement or a meeting summary. Although it is a board meeting resolution announcement, the detailed financial data and reports included align with the characteristics of an Annual Report (10-K). The document length is under 5,000 characters but contains actual financial data and detailed reports, so it is not a mere announcement or certification. Therefore, the correct classification is Annual Report (10-K). FY 2010
2011-03-18 Chinese
第七届监事会第四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the supervisory board of Mayinglong Pharmaceutical Group Co., Ltd. It discusses the approval of the 2010 Annual Report and its summary, the 2010 Supervisory Board Work Report, and the 2010 Internal Control Self-Evaluation Report. The document is short (823 characters) and primarily announces the approval of these reports rather than containing the full reports themselves. It does not contain detailed financial data or the full annual report content. Therefore, it is best classified as a Regulatory Filing (RNS) because it is an official announcement related to regulatory compliance and report approvals, not the full Annual Report (10-K) itself.
2011-03-18 Chinese
2010年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2010 年年度报告摘要" which translates to "2010 Annual Report Summary". It contains detailed financial data for the year 2010, including revenue, profit, assets, shareholder information, management discussion and analysis, and other comprehensive financial and operational details. The document is lengthy (15,000 characters) and includes substantive financial statements and analysis, not just an announcement or a brief summary. It also includes management discussion and analysis sections, detailed accounting data, shareholder information, and notes on capital usage, which are typical components of an Annual Report. Therefore, this document is best classified as an Annual Report (10-K). FY 2010
2011-03-18 Chinese
2010年年度报告
Annual Report Classification · 100% confidence The document is titled as the 2010 Annual Report of Mayinglong Pharmaceutical Group Co., Ltd. It contains comprehensive sections typical of an annual report, including company basic information, accounting data and business data summary, changes in share capital and shareholders, board and senior management details, corporate governance structure, shareholder meeting summaries, board and supervisory reports, important matters, and financial accounting reports. The length is substantial (15,000 characters), and it includes detailed financial data and management discussion. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2010
2011-03-18 Chinese
关于股东持股变动的公告
Major Shareholding Notification Classification · 100% confidence The document is a short announcement regarding a change in shareholding by a significant shareholder (武汉国有资产经营公司 and its concerted actor 华汉投资) involving a sale of shares and the resulting shareholding percentage. It is not a full report but a notification of a major shareholding change. The document length is only 410 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it fits the category of Major Shareholding Notification (MRQ).
2011-03-11 Chinese
关于股东持股变动的公告
Major Shareholding Notification Classification · 100% confidence The document is a short announcement regarding a change in shareholding by a significant shareholder (武汉国有资产经营公司) and its related party. It details the sale of shares and the resulting ownership percentage. The document is brief (416 characters) and focuses solely on shareholding changes, which fits the definition of a Major Shareholding Notification. There is no indication of financial statements, management discussion, or other report types. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2011-02-16 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.